To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers

NCT01738867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcoholism

Interventions

DRUG: GSK1521498
DRUG: Naltrexone (NTX)
DRUG: Placebo

Sponsor

GlaxoSmithKline